An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

C OVID-19 mRNA vaccines that saved millions of lives globally during the pandemic from 2021 onwards, have now been reported ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Breakthrough universal cancer vaccine using mRNA technology enters human trials, potentially working against all cancer types ...

(Reuters) -Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after beginning ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel highlighted various alleged “safety uncertainties” of the mRNA COVID-19 ...

Federal funding cuts to vaccine research have impacted scientists nationwide — and some of those cuts hit close to home.

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...